The SoZo® double-blind clinical study on humans, recently published in the Nutrition Journal, has been enthusiastically welcomed by Distributors in the field as, according to Janice Hymer, “the most powerful ammunition we have,”
“This makes it easier for us. We don’t have to make health claims,” she says. “Just present the study to people. We have the proof.” The pilot clinical study reported SoZo's exclusive CoffeeBerry®-based functional beverage reduces inflammatory markers in vivo. The study authors conclude that the results "justify further clinical investigations into the beneficial effects of the SoZo® beverage on human health."
"SoZo could not be happier with these results," said J. Larry Cantrell, SoZo Chairman. "When we partnered with FutureCeuticals to produce SoZo, we focused on creating a dynamic, great-tasting wellness product with proven health benefits."
"This new science confirms what we knew all along: SoZo is in a class set apart," Cantrell said. "The SoZo team and our distributors can be proud of the fact that SoZo offers a real platform for healthier living."
Warren Bauerfeld has already seen the study bear fruit. A contact he had been working with stumbled across the news release on the internet and immediately emailed Warren that she wanted to become a SoZoLife Distributor.
“This is absolutely a great tool,” Warren says of the published study. “It’s the foundation of our SoZo story. It’s great validation!”
Dana Mazurek is “pretty excited about it.” She has begun forwarding the study to others.
“This will be especially powerful for people concerned about their health,” she says. “The proof is in the pudding.” Adds MaryAnn Cohee, “In network marketing you always want to stand apart from other products. The study does that. It means SoZo does what we say it does.”
No comments:
Post a Comment